drugset / Trial / NCT03003143

Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients

NCT03003143

NaSingle-groupOpen-labelTreatment

Summary

Investigation of efficacy of vigabatrin in refractory autoimmune encephalitis patients

Timeline

Start
2016-11
Primary completion
2020-09-09
Completion
2020-09-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Vigabatrin Small molecule 500 mg

Indications